瘤突变负担和FAT3突变影响了手术切除小细胞肺癌的长期存活率
Xinyu Qian1, Lin Zhu2, Na Han2
1Department of Oncology, Hangzhou Cancer Hospital, Hangzhou First People's Hospital, Hangzhou, China.
Translational lung cancer research
|July 8, 2024
概括
高瘤突变负担 (TMB) 和FAT3突变可能预测手术后小细胞肺癌 (SCLC) 患者的长期生存率. 这一发现可能有助于确定可能在SCLC切除后获得更好的结果的患者.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 癌症研究 癌症研究
背景情况:
- 小细胞肺癌 (SCLC) 是侵略性的,在手术后复发率很高.
- 在SCLC患者中确定长期存活 (LTS) 的因素仍然是一个挑战.
- 了解长期和短期幸存者之间的分子差异至关重要.
研究的目的:
- 调查与手术切除SCLC的长期存活 (LTS) 相关的遗传特征.
- 为了比较基因组概况和LTS和短期生存 (STS) SCLC患者群体之间的瘤突变负担 (TMB).
主要方法:
- 对11名SCLC患者 (6名LTS,5名STS) 的瘤组织进行基因组分析和TMB分析.
- 使用下一代测序来评估基因组资料和计算TMB.
- 分析了分子特征,并在LTS和STS组之间进行了比较.
主要成果:
- 来自LTS患者的瘤组织与STS患者 (中位数~8.5突变/Mb) 相比,表现出明显更高的TMB (中位数~16.4突变/Mb).
- 在长期存活组中,FAT3突变仅在长期存活组中被发现.
- 在LTS和STS组之间观察到TMB显著差异的趋势 (P=0.08).
结论:
- 高非同义的TMB和FAT3突变可能是SCLC切除后长期生存的潜在指标.
- 这项研究突出了SCLC患者之间具有不同生存结果的关键分子区别.
- 需要进行更大规模的研究来验证这些初步发现.
更多相关视频
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
17.9K
11:15Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
24.3K
相关概念视频
02:53Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
01:21Cancer Survival Analysis
340
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
340
01:12Loss of Tumor Suppressor Gene Functions
4.8K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.8K
02:07Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K